194 related articles for article (PubMed ID: 9814455)
1. The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure.
Cardinal H; Brossard JH; Roy L; Lepage R; Rousseau L; D'Amour P
J Clin Endocrinol Metab; 1998 Nov; 83(11):3839-44. PubMed ID: 9814455
[TBL] [Abstract][Full Text] [Related]
2. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.
Brossard JH; Cloutier M; Roy L; Lepage R; Gascon-Barré M; D'Amour P
J Clin Endocrinol Metab; 1996 Nov; 81(11):3923-9. PubMed ID: 8923839
[TBL] [Abstract][Full Text] [Related]
5. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women.
Boucher A; D'Amour P; Hamel L; Fugère P; Gascon-Barré M; Lepage R; Ste-Marie LG
J Clin Endocrinol Metab; 1989 Apr; 68(4):831-6. PubMed ID: 2921312
[TBL] [Abstract][Full Text] [Related]
6. Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Rodriguez AP; Felsenfeld AJ
J Bone Miner Res; 1997 Mar; 12(3):347-55. PubMed ID: 9076577
[TBL] [Abstract][Full Text] [Related]
7. The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.
D'Amour P; Palardy J; Bahsali G; Mallette LE; DeLéan A; Lepage R
J Clin Endocrinol Metab; 1992 Mar; 74(3):525-32. PubMed ID: 1740486
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.
Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
J Clin Endocrinol Metab; 1994 Jul; 79(1):211-6. PubMed ID: 8027229
[TBL] [Abstract][Full Text] [Related]
9. Rate dependence of acute PTH release and association between basal plasma calcium and set point of calcium-PTH curve in dialysis patients.
De Cristofaro V; Colturi C; Masa A; Comelli M; Pedrini LA
Nephrol Dial Transplant; 2001 Jun; 16(6):1214-21. PubMed ID: 11390723
[TBL] [Abstract][Full Text] [Related]
10. Calcium-mediated parathyroid hormone suppression to assess progression of secondary hyperparathyroidism during treatment among incident dialysis patients.
Rodriguez M; Ureña-Torres P; Pétavy F; Cooper K; Farouk M; Goodman WG
J Clin Endocrinol Metab; 2013 Feb; 98(2):618-25. PubMed ID: 23365129
[TBL] [Abstract][Full Text] [Related]
11. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
Reichel H
Nephron Clin Pract; 2010; 114(4):c268-76. PubMed ID: 20090369
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
Heaf JG; Løkkegård H
J Nephrol; 1998; 11(4):203-10. PubMed ID: 9702872
[TBL] [Abstract][Full Text] [Related]
13. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
Messa P; Mioni G; Turrin D; Guerra UP
Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
[TBL] [Abstract][Full Text] [Related]
14. The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences.
Hardy-Yverneau P; Shenouda M; Moriniere P; Legallais C; Brazier M; Achard J; Fournier A
Clin Nephrol; 1998 Oct; 50(4):236-46. PubMed ID: 9799069
[TBL] [Abstract][Full Text] [Related]
15. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
16. Influence of vitamin D on parathyroid function in the elderly.
Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
[TBL] [Abstract][Full Text] [Related]
18. Dynamic tests of parathyroid hormone secretion using hemodialysis and calcium infusion cannot be compared.
Moysés RM; Pereira RC; Machado dos Reis L; Sabbaga E; Jorgetti V
Kidney Int; 1999 Aug; 56(2):659-65. PubMed ID: 10432406
[TBL] [Abstract][Full Text] [Related]
19. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.
Gohda T; Shou I; Fukui M; Funabiki K; Horikoshi S; Shirato I; Tomino Y
Am J Kidney Dis; 2002 Jun; 39(6):1255-60. PubMed ID: 12046039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]